Invesco’s Xeris Biopharma Holdings XERS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$599K Sell
103,294
-8,836
-8% -$58.6K ﹤0.01% 3087
2025
Q4
$880K Sell
112,130
-470,978
-81% -$3.71M ﹤0.01% 2967
2025
Q3
$4.75M Buy
583,108
+496,914
+577% +$3.3M ﹤0.01% 2255
2025
Q2
$403K Sell
86,194
-940,644
-92% -$4.31M ﹤0.01% 3261
2025
Q1
$5.64M Buy
1,026,838
+957,822
+1,388% +$3.87M ﹤0.01% 2090
2024
Q4
$234K Buy
69,016
+1,350
+2% +$4.34K ﹤0.01% 3487
2024
Q3
$193K Buy
67,666
+1,137
+2% +$2.92K ﹤0.01% 3526
2024
Q2
$150K Buy
66,529
+2,727
+4% +$5.5K ﹤0.01% 3699
2024
Q1
$141K Buy
63,802
+625
+1% +$1.62K ﹤0.01% 3708
2023
Q4
$148K Sell
63,177
-256,471
-80% -$473K ﹤0.01% 3620
2023
Q3
$595K Sell
319,648
-1,784,974
-85% -$4.09M ﹤0.01% 3119
2023
Q2
$5.51M Buy
2,104,622
+2,285
+0.1% +$5.82K ﹤0.01% 2183
2023
Q1
$3.43M Buy
2,102,337
+2,276
+0.1% +$2.85K ﹤0.01% 2402
2022
Q4
$2.79M Sell
2,100,061
-6,994
-0.3% -$9.87K ﹤0.01% 2510
2022
Q3
$3.29M Buy
2,107,055
+6,849
+0.3% +$11.3K ﹤0.01% 2426
2022
Q2
$3.23M Buy
2,100,206
+62,816
+3% +$133K ﹤0.01% 2495
2022
Q1
$5.22M Buy
2,037,390
+1,264
+0.1% +$3.09K ﹤0.01% 2354
2021
Q4
$5.97M Sell
2,036,126
-688
-0% -$1.49K ﹤0.01% 2310
2021
Q3
$4.99M Sell
2,036,814
-488
-0% -$1.42K ﹤0.01% 2386
2021
Q2
$8.29M Sell
2,037,302
-7,718
-0.4% -$29.5K ﹤0.01% 2171
2021
Q1
$9.22M Buy
2,045,020
+1,969
+0.1% +$10.6K ﹤0.01% 1997
2020
Q4
$10.1M Buy
2,043,051
+41,063
+2% +$205K ﹤0.01% 1809
2020
Q3
$11.9M Buy
2,001,988
+105
+0% +$420 ﹤0.01% 1572
2020
Q2
$5.33M Buy
2,001,883
+1,000,000
+100% +$3.48M ﹤0.01% 1959
2020
Q1
$1.95M Buy
1,001,883
+1,883
+0.2% +$8.1K ﹤0.01% 2409
2019
Q4
$7.05M Hold
1,000,000
﹤0.01% 1953
2019
Q3
$9.83M Hold
1,000,000
﹤0.01% 1749
2019
Q2
$11.4M Buy
+1,000,000
New +$10.5M ﹤0.01% 1693

Other funds holding XERS